Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.

Antiviral therapy - 1 Jan 2008

Bennett Diane E, Myatt Mark, Bertagnolio Silvia, Sutherland Donald, Gilks Charles F

Abstract excerpt

BACKGROUND: The World Health Organization (WHO) HIV drug resistance (HIVDR) threshold survey method was developed for surveillance of transmitted HIVDR in resource-limited countries. The method is being implemented with minimal resources as a routine public health activity to produce comparable results in multiple countries and areas within countries. Transmitted drug resistant HIV strains will be seen first in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Developing Countries

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Evidence-Based Medicine

Share to Health Care Surveys

Share to Health Policy

Share to National Health Programs

Share to Program Evaluation

Share to World Health Organization

Source

Identifiers

PMID: 18575189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.PMID 18575189Read ↗

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.Semantic proximity Read ↗

World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.Semantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.Semantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots.Semantic proximity Read ↗

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.Semantic proximity Read ↗

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.